Tlwm Has $1.25 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Tlwm boosted its position in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 1.4% during the second quarter, reports. The fund owned 2,610 shares of the healthcare conglomerate’s stock after buying an additional 37 shares during the quarter. UnitedHealth Group makes up 0.4% of Tlwm’s portfolio, making the stock its 23rd biggest position. Tlwm’s holdings in UnitedHealth Group were worth $1,254,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Chelsea Counsel Co. bought a new stake in UnitedHealth Group during the 4th quarter worth $27,000. 25 LLC acquired a new position in shares of UnitedHealth Group during the first quarter worth $28,000. Freedom Wealth Alliance LLC bought a new position in shares of UnitedHealth Group during the fourth quarter worth about $31,000. Cascade Investment Advisors Inc. bought a new position in UnitedHealth Group during the first quarter worth $28,000. Finally, Kalos Management Inc. acquired a new stake in UnitedHealth Group during the first quarter worth approximately $34,000. 85.69% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, CEO Andrew Witty sold 4,000 shares of the stock in a transaction on Wednesday, July 19th. The stock was sold at an average price of $506.19, for a total transaction of $2,024,760.00. Following the sale, the chief executive officer now owns 78,573 shares in the company, valued at approximately $39,772,866.87. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.35% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several research analysts recently issued reports on UNH shares. SVB Securities cut their target price on shares of UnitedHealth Group from $625.00 to $560.00 in a research note on Wednesday, June 14th. Mizuho decreased their price objective on UnitedHealth Group from $600.00 to $549.00 in a report on Tuesday, July 11th. Sanford C. Bernstein raised shares of UnitedHealth Group from a “market perform” rating to an “outperform” rating and raised their price target for the company from $595.00 to $603.00 in a research report on Tuesday, July 18th. began coverage on shares of UnitedHealth Group in a research report on Thursday, August 17th. They set a “buy” rating on the stock. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a research note on Thursday, September 14th. Two research analysts have rated the stock with a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $575.65.

Get Our Latest Stock Report on UnitedHealth Group

UnitedHealth Group Stock Down 0.1 %

UNH opened at $486.06 on Tuesday. The company has a current ratio of 0.80, a quick ratio of 0.80 and a debt-to-equity ratio of 0.68. The company has a market capitalization of $450.24 billion, a PE ratio of 21.75, a PEG ratio of 1.43 and a beta of 0.66. UnitedHealth Group Incorporated has a 1-year low of $445.68 and a 1-year high of $558.10. The firm’s 50 day simple moving average is $492.05 and its two-hundred day simple moving average is $486.73.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings data on Friday, July 14th. The healthcare conglomerate reported $6.14 EPS for the quarter, beating the consensus estimate of $5.92 by $0.22. The business had revenue of $92.90 billion for the quarter, compared to the consensus estimate of $90.97 billion. UnitedHealth Group had a return on equity of 26.72% and a net margin of 6.06%. The business’s revenue was up 15.6% on a year-over-year basis. During the same period in the previous year, the business earned $5.57 earnings per share. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 24.83 EPS for the current year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 19th. Shareholders of record on Monday, September 11th will be paid a $1.88 dividend. The ex-dividend date is Friday, September 8th. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group’s payout ratio is currently 33.65%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with's FREE daily email newsletter.